共 114 条
[1]
Friedman ND(2016)The negative impact of antibiotic resistance Clin Microbiol Infect 22 416-422
[2]
Temkin E(2009)Pharmacokinetic issues for antibiotics in the critically ill patient Crit Care Med 37 840-851
[3]
Carmeli Y(2008)Pharmacokinetic and pharmacodynamic properties of meropenem Clin Infect Dis 47 S32-S40
[4]
Roberts JA(2010)Comparing outcomes of meropenem administration strategies based on pharmacokinetic and pharmacodynamic principles: a qualitative systematic review Ann Pharmacother 44 557-564
[5]
Lipman J(2009)Bench-to-bedside review: appropriate antibiotic therapy in severe sepsis and septic shock--does the dose matter? Crit Care 13 214-807
[6]
Nicolau DP(2004)Meropenem administered as a prolonged infusion to treat serious gram-negative central nervous system infections Pharmacotherapy 24 803-2078
[7]
Perrott J(2009)A systematic review on clinical benefits of continuous administration of beta-lactam antibiotics Crit Care Med 37 2071-476
[8]
Mabasa VH(2012)Accurate detection of outliers and subpopulations with Pmetrics, a nonparametric and parametric pharmacometric modeling and simulation package for R Ther Drug Monit 34 467-2981
[9]
Ensom MHH(2009)Population modeling and Monte Carlo simulation study of the pharmacokinetics and antituberculosis pharmacodynamics of rifampin in lungs Antimicrob Agents Chemother 53 2974-890
[10]
Pea F(2015)Dosing regimen of meropenem for adults with severe burns: a population pharmacokinetic study with Monte Carlo simulations J Antimicrob Chemother 70 882-599